CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 64 enrolled
Drug / intervention
Reduced sittingbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03101228
NCT03101228N/ACompleted

Medical and Physiological Benefits and Mechanisms of Reduced Sitting Without Meeting the Current Physical Activity Recommendations

Turku University Hospital·interventional·Posted Apr 5, 2017·Updated Apr 8, 2020

In Brief

A clinical study evaluating Reduced sitting for Metabolic Syndrome and 3 related conditions. Completed, enrolled 64 participants across 1 site.

Detailed Summary

The most important objective of this randomized controlled trial in subjects with increased cardiovascular and metabolic risk factors is to investigate whether only reduced daily sitting improves human cardiovascular and metabolic health during a six-month intervention. It is hypothesized and expected that only reduced sitting, without formal physical activity or exercise training, affects favorably cardiovascular and metabolic health.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesFinland
CollaboratorsUKK Institute

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedApr 5, 2017
Enrollment StartApr 25, 2017
Primary CompletionFeb 14, 2020
Study CompletionMar 4, 2020
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 9.2 years ago

Interventions

Reduced sittingbehavioral

Subjects are guided to limit their sitting time during the day for 1 hour/day, by adding light activity with the help of an activity monitor. Subjects are not encouraged to increase their moderate to vigorous physical activity levels.